On 17 and 18 June, the GenoTher biocluster is organising the GenoTher Summit 2026 – Accelerating the Future of Genetic Medicine in Paris.
Bringing together leading experts from the fields of science, biotechnology, the pharmaceutical industry, clinical networks and regulation, this symposium offers an opportunity to discover the latest advances in genetic medicine, gene therapy and artificial intelligence applied to healthcare, whilst engaging with academic, clinical and industrial stakeholders.
Different perspectives on the main current challenges (manufacturability, safety, clinical trial design, access to treatments and sustainable distribution models) will be shared by key players in the sector: industrial partners, CDMOs/CROs, start-ups, investors and policy-makers.
Note that, as part of the Work Package on innovative tools for clinical applications in neuromuscular diseases led by the Institute of Myology, Bruno Cadot will give a flash presentation outlining the Work Package’s activities and progress during the session dedicated to the GenoTher ecosystem.
| GenoTher is Europe’s first biocluster dedicated exclusively to gene therapy. It offers a unique ecosystem for innovation, accelerated development, training and commercialisation in the field of gene therapy. > More |
GenoTher Summit 2026 programme
